Research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic rsearch, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
A research paper published in 2012 in Cancer Research by Kyrre E. Emblem (Intervention Centre, OUH) as the corresponding author is highlighted by the American Association of Cancer Research (AACR) as one of the most highly-cited AACR articles from date of publication until February 2014.
A project initiated by post doc Einar Vik-Mo and professor Iver Langmoen from the Department of Neurosurgery at OUS has drawn interest from Norwegian media. The major newspaper Aftenposten has recently presented his project in a feature article entitled "Norwegian physicians tailor make chemotherapy to each tumor".
Prospective isolation of tumour initiating cells is possible using tumour specific antigens. Vik-Mo, Langmoen and collaborators s are currently working on the isolation and characterization of such tumour initiating cells using primary cell cultures, both as floating neurosphere assays and adherent cultures, and combining this with FACS and MACS to prospectively isolate the putative tumour initiating cells.
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".
For the month of June 2014, this honour went to Karin Cecilie Lødrup Carlsen from the Department of Paediatric Medicine at the Women and Children's Division, Oslo University Hospital.
Professors Ragnhild A. Lothe, Guro E. Lind and Rolf Skotheim recently arranged a popular science event for the inhabitants of Røst with support from the mayor of Røst, Tor Andreassen, and the district medical officer, Kjell Arne Helgebostad.
Anne-Lise Børresen-Dale, head of the Department of Genetics at the Insitute for Cancer Research, has recently been selected for the The Helmholtz International Fellow Award For Excellent Researchers and Science Managers and is welcomed as an honorary member into the Helmholtz community.
Cooperation with the world's best researchers is a key objective of the Helmholtz Association's international activities. To this end, the organisation established the Helmholtz International Fellow Award in 2012, which targets outstanding senior scientists and research managers based outside Germany who have excelled in fields relevant to the Helmholtz Association, including science management at large international research institutions.
Jul 22, 2014
Jul 21, 2014
Jul 2, 2014
Selected latest publications
Journ. Impact factor > 8 First or last author from Oslo University Hospital
Reply: resting heart rate: an independent predictor of congestive heart failure
J Am Coll Cardiol, 64 (4), 422
More selected publications